Investment Case

Venture Life develops, manufactures, and distributes non-drug, prescription-free products for the self-care market to enable consumers to lead healthier lives.

Accumulating a decade of specialized expertise in self-care products, we are committed to empower consumers worldwide with an expanded range of health-enhancing options.

Mission, Vision and Value


We are globally dedicated to providing accessible, innovative self-care products to address consumers’ everyday needs.



To enhance our customers’ wellbeing by creating sustainable and effective self-care solutions for a better quality of life.



  • Innovative
  • Trust
  • Integrity
  • Consistent
  • Responsible


Culture & Behaviour:

  • Support & Development
  • Fun
  • Proactiveness
  • Inclusivity & Respect
  • Teamwork & Collaboration

Reasons to invest

  • Consistent high revenue growth
  • Steady margin improvement and strong cash generation
  • Advanced in-house R&D and manufacturing
  • Brand development and innovation
  • Strong distribution partnerships
  • Focus on sustainability
  • Shareholder value creation

Our business model

We have multiple revenue growth opportunities, both organically and through our acquisition strategy.

Our key activities Based on a vertically integrated approach, we either acquire or develop self-care products and brands. These products are then manufactured in-house and sold to a network of international partners as well as to key retailers and through online channels in the UK, The Netherlands and Italian markets.

Fully Integrated for growth

Our 5,500m2 facility is located in northern Italy, near Milan. This facility manufactures both our wholly owned Venture Life Brands and Customer Brands, which are sold under the customers’ brand names.

Our 2,600m2 Swedish facility is in Gnesta, south of Stockholm, and manufactures the bacterial vaginosis and moisture gel under our own brand of Balance Active, but also under customer brand names. It contains a state of the art fully automated filling line that can produce

270 long neck tubes per minute.

We have over 35 years of experience in developing consumer healthcare products (registered as Medical Devices or Cosmetics), and a strong technical team in place with regulatory expertise. This in-house ability to develop and manufacture allows us to be agile in responding to market demand.

Our development and manufacturing capability is a key revenue driver for the Group. With our strong growth to date and strategic ambition, we have invested significantly over the last couple of years to increase the manufacturing capacity.

Sustainable Growth

Our ESG (Environmental, Social, Governance) goals align with key Sustainable Development Goals (SDGs) to drive positive impact.

Check out our latest ESG strategy and practices.

Financial performance

+34%Group Revenue in 2022
+36%Gross profit in 2022
+35%Adjusted EBITDA in 2022

Widespread distribution network

Our growth hinges on our ongoing commitment to become the preferred “partner of choice” for self-care products. This entails cultivating and sustaining robust partnerships worldwide, while delivering the best-in-class standard of service.



Company presentation

For more detailed information please download our latest Company presentation: